eMedicine Specialties > Emergency Medicine > Toxicology
Toxicity, Mushroom - Gyromitra Toxin: Differential Diagnoses & Workup
Updated: Feb 29, 2008
- Overview
- Differential Diagnoses & Workup
- Treatment & Medication
- Follow-up
Differential Diagnoses
Other Problems to Be Considered
Shigellosis
Workup
Laboratory Studies
- Electrolytes, BUN, creatinine, and glucose
- Patients often are dehydrated.
- Assess renal function of patients with hemolysis.
- Hyperglycemia may be present as an acute stress reaction; however, sudden hypoglycemia is a greater concern than hyperglycemia with hepatic injury.
- Complete blood count and/or peripheral blood smear: Assess for anemia from hemolysis or blood loss.
- Hepatic transaminases and serum bilirubin
- Findings may be normal at presentation; however, if hepatic injury exists it becomes abnormal within days of exposure.
- Bilirubin may be elevated from hemolysis or liver toxicity.
- Methemoglobin levels: Measure by co-oximetry (determine need for methylene blue treatment).
- Tests for hemolysis
- Urinalysis: Positive dip test for blood without RBCs on microscopic analysis suggests either hemolyzed blood (hemoglobinuria) or myoglobin.
- Free plasma hemoglobin increases with hemolysis.
- Serum haptoglobin decreases with hemolysis.
- Blood smears: Heinz body formation is observed with special stains, and bite cells are observed with Wright stain.
Other Tests
- Determination of mushroom type
- If a specimen of the ingested mushroom is available, save it in a paper bag for potential identification. An experienced mycologist may identify the mushroom.
- Save any food specimen or gastric contents (from emesis); further testing for gyromitrin toxin occasionally may be performed.
- Gas-liquid chromatography, gas mass spectrometry, and thin-layer chromatography can be used to identify hydrazone and hydrazine compounds.
More on Toxicity, Mushroom - Gyromitra Toxin |
| Overview: Toxicity, Mushroom - Gyromitra Toxin |
Differential Diagnoses & Workup: Toxicity, Mushroom - Gyromitra Toxin |
| Treatment & Medication: Toxicity, Mushroom - Gyromitra Toxin |
| Follow-up: Toxicity, Mushroom - Gyromitra Toxin |
| References |
| « Previous Page | Next Page » |
References
Watson WA, Litovitz TL, Rodgers GC, et al. 2004 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med. Sep 2005;23(5):589-666. [Medline].
Watson WA, Litovitz TL, Klein-Schwartz W, et al. 2003 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med. Sep 2004;22(5):335-404. [Medline].
Watson WA, Litovitz TL, Rodgers GC, et al. 2002 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med. Sep 2003;21(5):353-421. [Medline].
Litovitz TL, Klein-Schwartz W, Rodgers GC, et al. 2001 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med. Sep 2002;20(5):391-452. [Medline].
Litovitz TL, Klein-Schwartz W, White S, et al. 2000 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med. Sep 2001;19(5):337-95. [Medline].
Litovitz TL, Klein-Schwartz W, White S, et al. 1999 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med. Sep 2000;18(5):517-74. [Medline].
Litovitz TL, Klein-Schwartz W, Caravati EM, et al. 1998 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med. Sep 1999;17(5):435-87. [Medline].
Litovitz TL, Klein-Schwartz W, Dyer KS, et al. 1997 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med. Sep 1998;16(5):443-97. [Medline].
Litovitz TL, Smilkstein M, Felberg L, et al. 1996 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med. Sep 1997;15(5):447-500. [Medline].
Hoppe-Roberts JM, Lloyd LM, Chyka PA. Poisoning mortality in the United States: comparison of national mortality statistics and poison control center reports. Ann Emerg Med. May 2000;35(5):440-8. [Medline].
Braun R, Greeff U, Netter KJ. Liver injury by the false morel poison gyromitrin. Toxicology. Feb 1979;12(2):155-63. [Medline].
Brent J, Kulig K. Mushrooms. In: Haddad LM, et al, eds. Clinical Management of Poisoning and Drug Overdose. 3rd ed. WB Saunders; 1998:365-74.
Karlson-Stiber C, Persson H. Cytotoxic fungi--an overview. Toxicon. Sep 15 2003;42(4):339-49. [Medline].
Leathem AM, Dorran TJ. Poisoning due to raw Gyromitra esculenta (false morels) west of the Rockies. CJEM. Mar 2007;9(2):127-30. [Medline].
Michelot D, Toth B. Poisoning by Gyromitra esculenta--a review. J Appl Toxicol. Aug 1991;11(4):235-43. [Medline].
Schneider A, Attaran M, Meier PN, Strassburg C, Manns MP, Ott M. Hepatocyte transplantation in an acute liver failure due to mushroom poisoning. Transplantation. Oct 27 2006;82(8):1115-6. [Medline].
Trestrail JH. Monomethylhydrazine-containing mushrooms. In: Spoerke DG, Rumack BH, eds. Handbook of Mushroom Poisoning: Diagnosis and Treatment. CRC Press LLC; 1994:279-87.
Yildirim C, Bayraktaroglu Z, Gunay N, Bozkurt S, Köse A, Yilmaz M. The use of therapeutic plasmapheresis in the treatment of poisoned and snake bite victims: an academic emergency department's experiences. J Clin Apher. Dec 2006;21(4):219-23. [Medline].
Further Reading
Keywords
mushroom poisoning, false morel mushrooms, Gyromitra esculenta, Gyromitra ambigua, Gyromitra infula, mushroom toxicity, gyromitra toxin, gyromitra poisoning, hydrazones, N -methyl-N-formylhydrazone, mushroom exposure, gyromitrin-containing mushrooms, poisonous mushrooms
Differential Diagnoses & Workup: Toxicity, Mushroom - Gyromitra Toxin